Drug:
Reaction: DRUG INEFFECTIVE
20250101 - 20251231
No. 501 - 600
| No. | safetyreportid |
occurcountry |
patientonsetage |
patientsex 1:M 2:F |
|---|---|---|---|---|
Adverse reaction |
||||
Drug (openfda.generic_name, medicinalproduct) |
||||
| 501 | 25134746 |
US |
||
Drug ineffective, |
||||
TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, PREDNISONE, NIVOLUMAB, NIVOLUMAB, IPILIMUMAB, IPILIMUMAB, RIBOCICLIB, RIBOCICLIB, ANASTROZOLE, ANASTROZOLE TABLETS, ANASTROZOLE, ANASTROZOLE TABLETS, |
||||
| 502 | 25134749 |
US |
39 | |
Malignant neoplasm progression, Drug ineffective, Depressed mood, |
||||
FULVESTRANT, FULVESTRANT, OLAPARIB, |
||||
| 503 | 25134754 |
US |
||
Drug ineffective, |
||||
HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, PREDNISONE, PEMBROLIZUMAB, |
||||
| 504 | 25134757 |
US |
25 | 1 |
Drug ineffective, |
||||
NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, DOBUTAMINE, |
||||
| 505 | 25134759 |
US |
65 | 2 |
Drug ineffective, |
||||
METHYLPREDNISOLONE, NIVOLUMAB, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, CISPLATIN, |
||||
| 506 | 25134776 |
CA |
66 | 2 |
Appendicitis, Drug ineffective, Abdominal pain lower, Off label use, |
||||
PRASTERONE, PRASTERONE, UPADACITINIB, |
||||
| 507 | 25134867 |
FR |
||
Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 508 | 25134901 |
US |
41 | 2 |
Radioisotope scan abnormal, Drug ineffective, |
||||
COPPER CU 64 DOTATATE, |
||||
| 509 | 25134908 |
US |
40 | 1 |
Drug ineffective, |
||||
FLUCONAZOLE, POSACONAZOLE, POSACONAZOLE DELAYED-RELEASE, AMPHOTERICIN B, CLADRIBINE, CYTARABINE, VENETOCLAX, |
||||
| 510 | 25134911 |
DE |
74 | 2 |
Drug ineffective, Paraneoplastic neurological syndrome, Anti-neuronal antibody, |
||||
ETOPOSIDE, ETOPOSIDE, CARBOPLATIN, CARBOPLATIN, ATEZOLIZUMAB, HUMAN IMMUNOGLOBULIN G, |
||||
| 511 | 25134916 |
US |
1 | |
Drug ineffective, |
||||
SUMATRIPTAN, SUMATRIPTAN SUCCINATE, |
||||
| 512 | 25134918 |
FR |
||
Drug ineffective, |
||||
AZACITIDINE, AZACITIDINE FOR, |
||||
| 513 | 25134950 |
BR |
||
Ophthalmic herpes zoster, Condition aggravated, Drug ineffective, Treatment noncompliance, |
||||
VALACYCLOVIR HYDROCHLORIDE, ACYCLOVIR, ROSUVASTATIN, ALENDRONATE SODIUM, |
||||
| 514 | 25134958 |
IT |
65 | 2 |
Chest pain, Drug ineffective, |
||||
TELMISARTAN, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, CITALOPRAM, CITALOPRAM HYDROBROMIDE, ATENOLOL, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, |
||||
| 515 | 25134960 |
US |
73 | 1 |
Drug ineffective, |
||||
| 516 | 25134975 |
US |
70 | 2 |
Drug ineffective, |
||||
LANSOPRAZOLE, DEXLANSOPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 517 | 25135008 |
US |
||
Drug ineffective, |
||||
RITLECITINIB, |
||||
| 518 | 25135010 |
US |
2 | |
Drug ineffective, Product availability issue, Suspected counterfeit product, Physical product label issue, |
||||
LISDEXAMFETAMINE DIMESYLATE, |
||||
| 519 | 25135018 |
CZ |
1 | |
Liver function test increased, Alcohol poisoning, Blood bilirubin increased, Fall, Alcoholism, Hepatic failure, Metastases to lymph nodes, Metastases to pancreas, Metastases to pelvis, Lung neoplasm malignant, Drug ineffective, Central nervous system lesion, |
||||
DABRAFENIB, DABRAFENIB, TRAMETINIB, TRAMETINIB, |
||||
| 520 | 25135027 |
US |
21 | 2 |
Drug ineffective, |
||||
OZANIMOD HYDROCHLORIDE, |
||||
| 521 | 25135029 |
US |
2 | |
Hallucination, Mania, Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 522 | 25135043 |
US |
20 | 2 |
Drug ineffective, |
||||
TOFACITINIB, |
||||
| 523 | 25135046 |
US |
74 | 2 |
Fatigue, Drug ineffective, Haemorrhage, Diarrhoea, Flatulence, |
||||
ETRASIMOD, |
||||
| 524 | 25135070 |
US |
30 | 1 |
Drug ineffective, Constipation, Feeding disorder, |
||||
ETRASIMOD, |
||||
| 525 | 25135099 |
US |
64 | 1 |
Drug ineffective, |
||||
DUPILUMAB, BUDESONIDE, |
||||
| 526 | 25135240 |
CA |
43 | 2 |
Breast cancer stage II, Breast cancer stage III, Deep vein thrombosis postoperative, Delirium, Disability, Dislocation of vertebra, Duodenal ulcer perforation, Epilepsy, Hip arthroplasty, Knee arthroplasty, Lower respiratory tract infection, Liver injury, Pemphigus, Pericarditis, Pneumonia, Psoriatic arthropathy, Pulmonary fibrosis, Rheumatic fever, Rheumatoid arthritis, Systemic lupus erythematosus, Type 2 diabetes mellitus, Drug intolerance, Drug ineffective, Intentional product use issue, Maternal exposure during pregnancy, Off label use, Product quality issue, Product use in unapproved indication, |
||||
ALENDRONATE SODIUM, ASCORBIC ACID, ASCORBIC ACID, ASCORBIC ACID, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, LEFLUNOMIDE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DESOXIMETASONE, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC, DICLOFENAC SODIUM, DICLOFENAC POTASSIUM, DICLOFENAC POTASSIUM, FILM COATED, DICLOFENAC POTASSIUM TABLETS, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, FOLIC ACID, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, HYDROCORTISONE, ANTIPRURITIC (ANTI-ITCH), ANTI-ITCH CREAM, HYDROCORTISONE 1%, HYDROCORTISONE CONTINUOUS SPRAY, ANTI-PRURITIC, HYDROCORTISONE LOTION, HYDROCORTISONE ACETATE, HYDROCORTISONE LOTION KIT, ANTI ITCH, ANTI-ITCH, COOL RELIEF GEL WITH ALOE, HYDROCORTISONE CREAM 1%, HYDROCORTISONE SPRAY, DRS. HYDROCORTISONE, LAMOTRIGINE, LAMOTRIGINE EXTENDED-RELEASE, LAMOTRIGINE CHEWABLE DISPERSIBLE, LAMOTIRIGINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, HYDROXYCHLOROQUINE, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METFORMIN HYDROCHLORIDE, METFORMIN, METFORMIN HYDROCHLORIDE EXTENDED-RELEASE TABLETS, METFORMIN HYDROCHLORIDE TABLET, METFORMIN HYDROCHLORIDE TABLETS, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, METHOTREXATE, METHOTREXATE SODIUM, PANTOPRAZOLE SODIUM, PANTOPRAZOLE, PANTOPRAZOLE SODIUM IN 0.9% SODIUM CHLORIDE, PANTOPRAZOLE SODIUM INJECTION, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PREDNISONE, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, PSEUDOEPHEDRINE HYDROCHLORIDE, PSEUDOEPHEDRINE HCL, RANITIDINE HYDROCHLORIDE, TRAMADOL HYDROCHLORIDE, TRIAMCINOLONE ACETONIDE, TRIAMCINOLONE ACETONIDE OINTMENT USP, 0.05%, |
||||
| 527 | 25135253 |
CA |
55 | 2 |
Condition aggravated, Drug ineffective, |
||||
METHOTREXATE, METHOTREXATE SODIUM, PREDNISONE, |
||||
| 528 | 25135295 |
US |
1 | |
Dialysis, Drug ineffective, |
||||
SPARSENTAN, SPARSENTAN, SPARSENTAN, |
||||
| 529 | 25135311 |
US |
||
Drug ineffective, |
||||
CARISOPRODOL, |
||||
| 530 | 25135326 |
US |
2 | |
Drug ineffective, |
||||
PIMAVANSERIN TARTRATE, |
||||
| 531 | 25135333 |
US |
1 | |
Drug ineffective, |
||||
CETIRIZINE HYDROCHLORIDE, LORATADINE, LORATADINE TABLET, GLIPIZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, LOSARTAN, ASPIRIN, ASPIRIN 81 MG, ASPIRIN 325 MG, OMALIZUMAB, |
||||
| 532 | 25135339 |
CA |
||
Hypertransaminasaemia, Hypertriglyceridaemia, Gastrointestinal disorder, Increased appetite, Drug ineffective, |
||||
PEGASPARGASE, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, DEXAMETHASONE, DEXAMETHASONE 1.5 MG, GEMFIBROZIL, METHOTREXATE, METHOTREXATE SODIUM, MERCAPTOPURINE, ICOSAPENT ETHYL, DEXTROSE MONOHYDRATE, DEXTROSE, |
||||
| 533 | 25135389 |
US |
53 | 2 |
Drug ineffective, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, DOCETAXEL, DOCETAXEL ANHYDROUS, |
||||
| 534 | 25135435 |
US |
||
Drug ineffective, No adverse event, |
||||
TRIAMCINOLONE ACETONIDE, |
||||
| 535 | 25135504 |
PL |
||
Chronic kidney disease, Toxicity to various agents, Metastases to lung, Hyperaesthesia, Decreased appetite, Anaemia, Polyneuropathy in malignant disease, Metastases to bone, Product use in unapproved indication, Drug dependence, Constipation, Quality of life decreased, Confusional state, Dermatitis allergic, Drug ineffective, Polyneuropathy, Allodynia, Confusional state, Decreased appetite, Malignant neoplasm progression, Neuropathy peripheral, Pain, Prostate cancer, |
||||
ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, LEUPROLIDE, LEUPROLIDE, PREGABALIN, PREGABALIN, FENTANYL, FENTANYL, FENTANYL, FENTANYL, FENTANYL, MORPHINE SULFATE, DOCETAXEL, DOCETAXEL ANHYDROUS, KETOPROFEN, KETOPROFEN, GABAPENTIN, GABAPENTIN, GABAPENTIN, GABAPENTIN, DENOSUMAB, BICALUTAMIDE, MORPHINE, MORPHINE, MORPHINE, ERGOCALCIFEROL, IRON, ABIRATERONE ACETATE, ABIRATERONE, BICALUTAMIDE, GABAPENTIN, GABAPENTIN, DENOSUMAB, KETOPROFEN, DICLOFENAC, DICLOFENAC SODIUM, |
||||
| 536 | 25135519 |
|||
Drug intolerance, Drug ineffective, Fatigue, Anxiety, Depression, |
||||
SUVOREXANT, |
||||
| 537 | 25135520 |
CA |
48 | 2 |
Colectomy, Drug ineffective, |
||||
VEDOLIZUMAB, INFLIXIMAB, |
||||
| 538 | 25135545 |
TR |
||
Diabetes mellitus, Disturbance in attention, Brain fog, Incorrect dose administered, Overdose, Drug ineffective, |
||||
METHYLPHENIDATE HYDROCHLORIDE, |
||||
| 539 | 25135584 |
US |
||
Product storage error, Drug ineffective, |
||||
ALENDRONATE SODIUM, ALENDRONATE SODIUM TABLET, |
||||
| 540 | 25135610 |
US |
||
Drug ineffective, |
||||
MELOXICAM, GABAPENTIN, DIAZEPAM, |
||||
| 541 | 25135655 |
24 | 1 | |
Drug ineffective, |
||||
LEVETIRACETAM, LEVETIRACETAM ORAL, LEVETIRACETAM INJECTION, LEVETIRACETAM IN SODIUM CHLORIDE, LEVETIRACETAM, |
||||
| 542 | 25135680 |
US |
2 | |
Rash, Drug ineffective, |
||||
ADALIMUMAB, |
||||
| 543 | 25135757 |
US |
2 | |
Rash, Drug ineffective, |
||||
DUPILUMAB, |
||||
| 544 | 25135783 |
US |
||
Drug ineffective, |
||||
NAPROXEN SODIUM, NAPROXEN SODIUM TABLET, |
||||
| 545 | 25135795 |
US |
79 | 2 |
Acne, Skin disorder, Haemorrhage, Skin exfoliation, Dry skin, Drug ineffective, |
||||
CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, CLOBETASOL PROPIONATE, CLOBETASOL PROPIONATE OINTMENT USP, 0.05%, KETOCONAZOLE, KETOCONAZOLE FOAM, KETOCONAZOLE CREAM, 2%, NYSTATIN, NYSTATIN OINTMENT, NYSTATIN CREAM, METOPROLOL TARTRATE, METOPROLOL, |
||||
| 546 | 25135804 |
US |
||
Drug ineffective, |
||||
| 547 | 25135805 |
US |
69 | 2 |
Dizziness, Somnolence, Drug ineffective, Condition aggravated, |
||||
IPRATROPIUM BROMIDE, |
||||
| 548 | 25135828 |
CA |
78 | 2 |
Abdominal pain upper, Anaemia, Aspiration, Asthenia, Asthma, Blood calcium increased, Blood creatinine increased, Blood test abnormal, Bronchiectasis, Bronchopulmonary aspergillosis allergic, Constipation, Cough, Drug hypersensitivity, Drug ineffective, Dyspnoea, Fatigue, Gastrooesophageal reflux disease, General physical health deterioration, Haemoptysis, Headache, Hypoxia, Liver function test increased, Lower respiratory tract infection, Lung opacity, Musculoskeletal stiffness, Obstructive airways disorder, Oedema peripheral, Pain, Pleural effusion, Pleuritic pain, Pneumonia, Pulmonary fibrosis, Pulmonary mass, Pyrexia, Rales, Sputum discoloured, Total lung capacity decreased, Transaminases increased, Tremor, Upper respiratory tract infection, Wheezing, Product dose omission issue, |
||||
MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, MONTELUKAST SODIUM, MOMETASONE FUROATE, MOMETASONE FUROATE, MOMETASONE FUROATE, MOMETASONE FUROATE, MONTELUKAST SODIUM, MONTELUKAST, MONTELUKAST SODIUM, MONTELUKAST, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, IPRATROPIUM BROMIDE, AZITHROMYCIN, AZITHROMYCIN MONOHYDRATE, AZITHROMYCIN DIHYDRATE, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, BISACODYL, BISACODYL SUPPOSITORIES, BISCODYL, CANDESARTAN, DEXLANSOPRAZOLE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, FORMOTEROL FUMARATE, FORMOTEROL FUMARATE DIHYDRATE, NITROGLYCERIN, NITROGLYCERIN, EFINACONAZOLE, EFINACONAZOLE, EFINACONAZOLE, LANSOPRAZOLE, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, MOMETASONE, NITROGLYCERIN, MEPOLIZUMAB, MEPOLIZUMAB, OMALIZUMAB, OMALIZUMAB, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PANTOPRAZOLE, PRAMIPEXOLE, PRAMIPEXOLE, PRAMIPEXOLE, PRAMIPEXOLE, PREGABALIN, PREGABALIN, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, LANSOPRAZOLE, PYRILAMINE MALEATE, PYRILAMINE MALEATE, PYRILAMINE MALEATE, QUETIAPINE FUMARATE, QUETIAPINE, QUETIAPINE FUMARATE, QUETIAPINE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RANITIDINE HYDROCHLORIDE, RISEDRONATE SODIUM, ROSUVASTATIN CALCIUM, ROSUVASTATIN CALCIUM, ALBUTEROL SULFATE, ALBUTEROL, ALBUTEROL SULFATE, ALBUTEROL, SENNA LEAF, SENNOSIDES, SENNOSIDES, SENNOSIDES, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, STANDARDIZED SENNA CONCENTRATE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, TIOTROPIUM BROMIDE, SIMVASTATIN, LEVOTHYROXINE SODIUM, ALBUTEROL SULFATE, |
||||
| 549 | 25135913 |
US |
2 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 550 | 25135941 |
US |
2 | |
Drug ineffective, Paraesthesia, Dysarthria, Dysarthria, Blepharospasm, Hypoaesthesia, |
||||
OXALIPLATIN, FLUOROURACIL, ATROPINE SULFATE, ATROPINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, LORAZEPAM, METHYLPREDNISOLONE, FAMOTIDINE, LORAZEPAM, HYDROCORTISONE ACETATE, |
||||
| 551 | 25135982 |
JP |
60 | 2 |
Decreased appetite, Electrocardiogram QT prolonged, Insomnia, Drug ineffective, Hypomania, |
||||
ESCITALOPRAM, OLANZAPINE, OLANZAPINE, OLANZAPINE, MIRTAZAPINE, |
||||
| 552 | 25136043 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 553 | 25136061 |
US |
2 | |
Drug ineffective, |
||||
SITAGLIPTIN, GLIPIZIDE, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, |
||||
| 554 | 25136074 |
US |
2 | |
Drug ineffective, |
||||
ARIPIPRAZOLE LAUROXIL, |
||||
| 555 | 25136099 |
US |
1 | |
Drug ineffective, |
||||
NALTREXONE, |
||||
| 556 | 25136146 |
US |
2 | |
Psoriatic arthropathy, Drug ineffective, |
||||
GOLIMUMAB, |
||||
| 557 | 25136152 |
FR |
||
Surgery, Drug ineffective, Off label use, |
||||
USTEKINUMAB, USTEKINUMAB, |
||||
| 558 | 25136178 |
UY |
68 | 2 |
Psoriatic arthropathy, Stomatitis, Hypersensitivity, Swelling face, Pyrexia, Decreased appetite, Oesophageal pain, COVID-19, Drug ineffective, |
||||
GOLIMUMAB, HYDROCORTISONE, |
||||
| 559 | 25136200 |
US |
||
Throat irritation, Nasal discomfort, Chest discomfort, Drug ineffective, Headache, Product formulation issue, |
||||
METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, |
||||
| 560 | 25136224 |
US |
2 | |
Malignant neoplasm progression, Drug ineffective, |
||||
GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, GEMCITABINE HYDROCHLORIDE, GEMCITABINE, |
||||
| 561 | 25136235 |
|||
Drug ineffective, |
||||
GLIPIZIDE, |
||||
| 562 | 25136276 |
US |
2 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 563 | 25136281 |
|||
Drug ineffective, |
||||
DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE ASPARTATE, DEXTROAMPHETAMINE SULFATE, AND AMPHETAMINE SULFATE, DEXTROAMPHETAMINE SULFATE, DEXTROAMPHETAMINE SACCHARATE, AMPHETAMINE SULFATE AND AMPHETAMINE ASPARTATE, |
||||
| 564 | 25136283 |
US |
57 | 2 |
Drug ineffective, |
||||
EPTINEZUMAB-JJMR, |
||||
| 565 | 25136285 |
US |
2 | |
Amputation, Drug ineffective, |
||||
APREMILAST, ETANERCEPT, LEVOTHYROXINE SODIUM, LEVOTHYROXINE SODIUM ANHYDROUS, |
||||
| 566 | 25136291 |
US |
53 | 2 |
Drug ineffective, |
||||
HEPARIN SODIUM, |
||||
| 567 | 25136292 |
US |
53 | 2 |
Drug ineffective, |
||||
EPINEPHRINE, ADRENALINUM, |
||||
| 568 | 25136293 |
US |
58 | 2 |
Drug ineffective, |
||||
EPINEPHRINE, ADRENALINUM, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, DOBUTAMINE, VASOPRESSIN, CALCIUM CHLORIDE INJECTION, CALCIUM CHLORIDE, |
||||
| 569 | 25136296 |
IT |
59 | 1 |
Drug ineffective, |
||||
METOPROLOL TARTRATE, METOPROLOL, |
||||
| 570 | 25136297 |
US |
26 | 1 |
Drug ineffective, |
||||
NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, NOREPINEPHRINE (BITARTRATE), NOREPINEPHRINE, NOREPINEPHRINE BITARTRATE, VASOPRESSIN, VASOPRESSIN, |
||||
| 571 | 25136298 |
US |
56 | 2 |
Rash, Headache, Drug ineffective, |
||||
BUDESONIDE, |
||||
| 572 | 25136301 |
US |
62 | 1 |
Drug ineffective, |
||||
MAGNESIUM, WARFARIN, |
||||
| 573 | 25136310 |
|||
Drug ineffective, |
||||
DULAGLUTIDE, |
||||
| 574 | 25136311 |
|||
Drug ineffective, |
||||
| 575 | 25136313 |
|||
Drug ineffective, |
||||
RAMELTEON, |
||||
| 576 | 25136323 |
US |
32 | 1 |
Drug ineffective, |
||||
BIVALIRUDIN, APIXABAN, |
||||
| 577 | 25136374 |
US |
66 | 2 |
Drug ineffective, |
||||
BUDESONIDE, |
||||
| 578 | 25136383 |
US |
53 | 2 |
Nightmare, Dissociation, Pain in extremity, Abdominal discomfort, Fatigue, Brain fog, Drug ineffective, |
||||
SUZETRIGINE, ACETAMINOPHEN, |
||||
| 579 | 25136410 |
FR |
68 | 2 |
Hypotension, Drug ineffective, |
||||
FOSCARBIDOPA/FOSLEVODOPA, |
||||
| 580 | 25136435 |
CA |
42 | 1 |
Ileocaecal resection, Frequent bowel movements, Defaecation urgency, Weight increased, Faecal calprotectin increased, Drug ineffective, Abdominal pain, Haematochezia, |
||||
UPADACITINIB, |
||||
| 581 | 25136456 |
US |
||
Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
| 582 | 25136463 |
ES |
38 | 2 |
Enterococcal infection, Meningitis, Drug ineffective, Disease progression, |
||||
PREDNISONE, DOXORUBICIN, ETOPOSIDE, RITUXIMAB, CYCLOPHOSPHAMIDE FOR INJECTION, CYCLOPHOSPHAMIDE, CYCLOPHOSPHAMIDE INJECTION, SOLUTION, IFOSFAMIDE, CISPLATIN, CYTARABINE, |
||||
| 583 | 25136478 |
US |
2 | |
Impaired quality of life, Drug ineffective, |
||||
DUPILUMAB, DUPILUMAB, |
||||
| 584 | 25136488 |
US |
2 | |
Drug ineffective, Weight increased, Weight decreased, Glycosylated haemoglobin increased, Foot deformity, Hypoaesthesia, Headache, Migraine, |
||||
LISINOPRIL, METFORMIN, METFORMIN ER 500 MG, METFORMIN ER 750 MG, DULAGLUTIDE, ERGOCALCIFEROL, EMPAGLIFLOZIN, MAGNESIUM, OXYCODONE AND ACETAMINOPHEN, OXYCODONE HYDROCHLORIDE AND ACETAMINOPHEN, OXYCODONE AND ACETAMINOPHEN TABLETS, |
||||
| 585 | 25136505 |
US |
||
Alopecia, Drug ineffective, |
||||
| 586 | 25136534 |
US |
2 | |
Skin disorder, Drug ineffective, Blood test abnormal, |
||||
ADALIMUMAB, |
||||
| 587 | 25136590 |
US |
2 | |
Drug ineffective, |
||||
DUPILUMAB, |
||||
| 588 | 25136614 |
US |
2 | |
Drug ineffective, |
||||
IPTACOPAN, |
||||
| 589 | 25136616 |
US |
1 | |
Drug ineffective, |
||||
TESTOSTERONE, TESTOSTERONE,, |
||||
| 590 | 25136628 |
US |
2 | |
Skin weeping, Skin haemorrhage, Condition aggravated, Pruritus, Injection site pain, Drug ineffective, |
||||
DUPILUMAB, LATANOPROST, METOPROLOL SUCCINATE, METOPROLOL SUCCINATE ER TABLETS, ZOLPIDEM TARTRATE, LEVOTHYROXINE SODIUM, AMOXICILLIN, AMLODIPINE BESYLATE, FUROSEMIDE, |
||||
| 591 | 25136629 |
US |
28 | 2 |
Drug ineffective, Off label use, |
||||
NEOSTIGMINE, ATROPINE SULFATE, ATROPINE, |
||||
| 592 | 25136651 |
US |
||
Drug ineffective, |
||||
| 593 | 25136680 |
US |
2 | |
Drug ineffective, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 594 | 25136682 |
US |
2 | |
Drug ineffective, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 595 | 25136684 |
US |
2 | |
Drug ineffective, Eye irritation, Product quality issue, |
||||
CYCLOSPORINE OPHTHALMIC SOLUTION, |
||||
| 596 | 25136691 |
BR |
2 | |
Thyroid disorder, Off label use, Blood thyroid stimulating hormone increased, Drug ineffective, |
||||
VONOPRAZAN FUMARATE, PANTOPRAZOLE, ESOMEPRAZOLE, ESOMEPRAZOLE MAGNESIUM, |
||||
| 597 | 25136713 |
US |
2 | |
Drug ineffective, |
||||
SECUKINUMAB, |
||||
| 598 | 25136726 |
CA |
76 | 1 |
Drug ineffective, Balance disorder, Dizziness, Erythema, Fall, Immunisation reaction, Influenza, Leukaemia, Malaise, Myasthenia gravis, Nasopharyngitis, Oedema peripheral, Paraesthesia, Syncope, Off label use, |
||||
RITUXIMAB, RITUXIMAB, RITUXIMAB, ACETAMINOPHEN, ACETAMINOPHEN ORAL SOLUTION, ACETAMINOPHEN TABLET EXTENDED RELEASE, PAIN RELIEVER, ACETAMINOPHEN, DIPHENHYDRAMINE HCL, DIPHENHYDRAMINE, DIPHENHYDRAMINE HYDROCHLORIDE, METHYLPREDNISOLONE, |
||||
| 599 | 25136776 |
US |
||
Drug ineffective, |
||||
TIRZEPATIDE, |
||||
| 600 | 25136801 |
US |
2 | |
Drug ineffective, |
||||
ONABOTULINUMTOXINA, |
||||
disclaimer
Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.
terms
license
last_updated
2025-04-28